Millennium Management’s Novavax NVAX Stock Holding History

Millennium Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$183K	Sell	22,500 -20,000	-47%	-$181K	﹤0.01%	5211
2025 Q4	$286K	Hold	42,500	–	–	﹤0.01%	5286
2025 Q3	$368K	Buy	+42,500	New	+$331K	﹤0.01%	5249
2024 Q4	–	Sell	-150,000	Closed	-$1.89M	–	6296
2024 Q3	$1.89M	Sell	150,000 -51,300	-25%	-$662K	﹤0.01%	3750
2024 Q2	$2.55M	Buy	+201,300	New	+$2.03M	﹤0.01%	3316
2023 Q4	–	Sell	-125,000	Closed	-$905K	–	6390
2023 Q3	$905K	Buy	+125,000	New	+$999K	﹤0.01%	4252
2022 Q3	–	Sell	-39,000	Closed	-$2.01M	–	7365
2022 Q2	$2.01M	Sell	39,000 -1,000	-3%	-$51.8K	﹤0.01%	3708
2022 Q1	$2.95M	Buy	40,000 +34,500	+627%	+$3.08M	﹤0.01%	3514
2021 Q4	$787K	Buy	+5,500	New	+$945K	﹤0.01%	4636
2021 Q3	–	Sell	-1,000	Closed	-$212K	–	7102
2021 Q2	$212K	Buy	+1,000	New	+$183K	﹤0.01%	5980
2016 Q4	–	Sell	-2,500	Closed	-$104K	–	3599
2016 Q3	$104K	Buy	+2,500	New	+$323K	﹤0.01%	3121

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's NVAX Position: Q1 2026 in Review

Millennium Management reduced its Novavax (NVAX) stake by 14% in Q1 2026, selling an estimated $5.6M and leaving 3,852,545 shares worth $31.4M. The position accounts for 0.01% of the portfolio, ranked #1194.

Millennium Management first reported a position in NVAX in Q3 2013 and has held it in 49 quarters since. The position peaked at $68.9M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Millennium Management held 3,852,545 shares of Novavax worth $31.4M as of Q1 2026.
Millennium Management sold 617,538 Novavax shares in Q1 2026, an estimated $5.6M.
Novavax made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1194 holding.
Millennium Management first reported a position in Novavax in Q3 2013 and has held it in 49 quarters since.
Millennium Management's Novavax position peaked at $68.9M in Q2 2021.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.